Related references
Note: Only part of the references are listed.Extended-release niacin/laropiprant improves endothelial function in patients after myocardial infarction
Urska Bregar et al.
HEART AND VESSELS (2014)
Niacin improves lipid profile but not endothelial function in patients with coronary artery disease on high dose statin therapy
Andrew C. Philpott et al.
ATHEROSCLEROSIS (2013)
Does PPARγ2 Gene Pro12Ala Polymorphism Affect Nonalcoholic Fatty Liver Disease Risk? Evidence from a Meta-Analysis
Amirhossein Sahebkar
DNA AND CELL BIOLOGY (2013)
The Current State of Niacin in Cardiovascular Disease Prevention A Systematic Review and Meta-Regression
Paul M. Lavigne et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Effect of Antioxidant Vitamin Supplementation on Cardiovascular Outcomes: A Meta-Analysis of Randomized Controlled Trials
Yizhou Ye et al.
PLOS ONE (2013)
Niacin in Cardiovascular Disease: Recent Preclinical and Clinical Developments
Janet E. Digby et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Meta-analysis of the effects of statin therapy on endothelial function in patients with diabetes mellitus
Lin Zhang et al.
ATHEROSCLEROSIS (2012)
Effect of omega-3 fatty acids supplementation on endothelial function: A meta-analysis of randomized controlled trials
Qianqian Wang et al.
ATHEROSCLEROSIS (2012)
Health benefits of high-density lipoproteins in preventing cardiovascular diseases
Hicham Berrougui et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2012)
On-Treatment Non-High-Density Lipoprotein Cholesterol, Apolipoprotein B, Triglycerides, and Lipid Ratios in Relation to Residual Vascular Risk After Treatment With Potent Statin Therapy JUPITER (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin)
Samia Mora et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Dysfunctional HDL: A novel important diagnostic and therapeutic target in cardiovascular disease?
Aneta Otocka-Kmiecik et al.
PROGRESS IN LIPID RESEARCH (2012)
Oxidative stress and endothelial dysfunction: Therapeutic implications
Tommaso Gori et al.
ANNALS OF MEDICINE (2011)
Niacin results in reduced monocyte adhesion in patients with type 2 diabetes mellitus
S. Tavintharan et al.
ATHEROSCLEROSIS (2011)
Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
William E. Boden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Nicotinic acid (niacin): new lipid-independent mechanisms of action and therapeutic potentials
Martina Lukasova et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Short-term effects of extended-release niacin on endothelial function in HIV-infected patients on stable antiretroviral therapy
Dominic C. Chow et al.
AIDS (2010)
Evidence That Niacin Inhibits Acute Vascular Inflammation and Improves Endothelial Dysfunction Independent of Changes in Plasma Lipids
Ben J. Wu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Endothelial-Vasoprotective Effects of High-Density Lipoprotein Are Impaired in Patients With Type 2 Diabetes Mellitus but Are Improved After Extended-Release Niacin Therapy
Sajoscha A. Sorrentino et al.
CIRCULATION (2010)
Niacin improves small artery vasodilatory function and compliance in statin-treated type 2 diabetic patients
Sandra J. Hamilton et al.
DIABETES & VASCULAR DISEASE RESEARCH (2010)
The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6-HDL and LDL Treatment Strategies in Atherosclerosis) Final Results and the Impact of Medication Adherence, Dose, and Treatment Duration
Todd C. Villines et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
C. Baigent et al.
LANCET (2010)
Niacin stimulates adiponectin secretion through the GPR109A receptor
Eric P. Plaisance et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Impact of age, sex, and exercise on brachial artery flow-mediated dilatation
Mark A. Black et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Effects of oral niacin on endothelial dysfunction in patients with coronary artery disease: Results of the randomized, double-blind, placebo-controlled INEF study
Ascan Warnholtz et al.
ATHEROSCLEROSIS (2009)
Niacin inhibits vascular oxidative stress, redox-sensitive genes, and monocyte adhesion to human aortic endothelial cells
Shobha H. Ganji et al.
ATHEROSCLEROSIS (2009)
Predictive Value of Brachial Flow-Mediated Dilation for Incident Cardiovascular Events in a Population-Based Study The Multi-Ethnic Study of Atherosclerosis
Joseph Yeboah et al.
CIRCULATION (2009)
Effects of High-Dose Modified-Release Nicotinic Acid on Atherosclerosis and Vascular Function A Randomized, Placebo-Controlled, Magnetic Resonance Imaging Study
Justin M. S. Lee et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Extended-Release Niacin or Ezetimibe and Carotid Intima-Media Thickness
Allen J. Taylor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
David Moher et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
The role of inflammatory cytokines in endothelial dysfunction
Cuihua Zhang
BASIC RESEARCH IN CARDIOLOGY (2008)
Efficacy of controlled-release niacin in treatment of metabolic syndrome: Correlation to surrogate markers of atherosclerosis, vascular reactivity, and inflammation
Christopher S. Vaccari et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2007)
The effects of extended-release niacin on carotid intimal media thickness, endothelial function and inflammatory markers in patients with the metabolic syndrome
M. Thoenes et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2007)
Extended-release niacin raises adiponectin and leptin
Sabine Westphal et al.
ATHEROSCLEROSIS (2007)
The effect of 24 months of combination statin and extended-release niacin on carotid intima-media thickness: ARBITER 3
Allen J. Taylor et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
Accumulation of chylomicron remnants and impaired vascular reactivity occur in subjects with isolated low HDL cholesterol:: Effects of niacin treatment
Alexandre M. Benjo et al.
ATHEROSCLEROSIS (2006)
High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I
D Seetharam et al.
CIRCULATION RESEARCH (2006)
New perspectives on the use of niacin in the treatment of lipid disorders
J McKenney
ARCHIVES OF INTERNAL MEDICINE (2004)
Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease
EM Wrone et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Arterial biology for the investigation of the treatment effects of reducing cholesterol (ARBITER) 2 - A double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins
AJ Taylor et al.
CIRCULATION (2004)
Role of endothelial dysfunction in atherosclerosis
J Davignon et al.
CIRCULATION (2004)
Free fatty acid levels modulate microvascular function -: Relevance for obesity-associated insulin resistance, hypertension, and microangiopathy
RT de Jongh et al.
DIABETES (2004)
Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia - Endothelial assessment of risk from lipids in youth (EARLY) trial
MM Engler et al.
CIRCULATION (2003)
Effect of Atorvastatin on postcardiac transplant increase in low-density lipoprotein cholesterol reduces development of intimal hyperplasia and progression of endothelial dysfunction
VY See et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein
RJ Bisoendial et al.
CIRCULATION (2003)
Obesity, adiponectin and vascular inflammatory disease
N Ouchi et al.
CURRENT OPINION IN LIPIDOLOGY (2003)
Cardiovascular disease outcomes during 6.8 years of hormone therapy - Heart and Estrogen/progestin Replacement Study follow-up (HERS II)
D Grady et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
A novel mechanism for the beneficial vascular effects of high-density lipoprotein cholesterol:: Enhanced vasorelaxation and increased endothelial nitric oxide synthase expression
JT Kuvin et al.
AMERICAN HEART JOURNAL (2002)
High density lipoprotein binding to scavenger receptor, class B, type I activates endothelial nitric-oxide synthase in a ceramide-dependent manner
XA Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease
BG Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Late prognostic value of flow-mediated vasodilation in the brachial artery of patients with chest pain
T Neunteufl et al.
AMERICAN JOURNAL OF CARDIOLOGY (2000)
Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis
S Duval et al.
BIOMETRICS (2000)
High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae
A Uittenbogaard et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
